Hypothyroidism Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017

  • ID: 4426703
  • Report
  • Region: Global
  • 152 Pages
  • VPA Research
10 % OFF
until Nov 30th 2018
1 of 5
The Report Focuses on Drugs and Therapies Being Evaluated for Hypothyroidism Treatment in Active Clinical Development Phases Including Phase 1, Phase 2, Phase 3 and Phase 4 Clinical Trials

FEATURED COMPANIES

  • Azienda USL Modena
  • Bracco S.p.A.
  • GlaxoSmithKline
  • Ipe, LLC
  • Shri Karthikeya Pharma
  • UNI-PHARMA SA
  • MORE

Hypothyroidism clinical trials report provides comprehensive analysis and trends in global Hypothyroidism disease clinical trials. The research work analyzes the evolution of Hypothyroidism clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Hypothyroidism treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner offering quick access to Hypothyroidism clinical trials.

Major drugs under development in Hypothyroidism are provided in the report along with their details of Mechanism of Action, Route of Administration, Target, therapy, molecule and class.

Scope of the Report:

  • Number of Hypothyroidism clinical trials across regions- Asia and Oceania, Europe, Middle East Africa and Americas
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Hypothyroidism
  • Both observational and interventional trials analyzed
  • Success rates of trials are analyzed
  • Trends in enrollment over the past ten years identified
  • Leading sponsors of Hypothyroidism clinical trials worldwide are listed

Reasons to Buy:

  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market

Hypothyroidism is a thyroid disorder where thyroid gland secretes less triiodothyronine (T3) and thyroxine (T4) inadequate to meet peripheral tissue demand. To compensate the decline in T3 and T4 levels, thyroid stimulating hormone (TSH) is produced in the pituitary gland.

These hormones regulate metabolism in the body and irregular secretion leads to disturbances in metabolism and energy storage. Further, normal functioning of brain, heart, muscles, and other organs can also be affected.

Auto-immune diseases, thyroidectomy, radiotherapy, radioiodine thyroid ablation typically cause hypothyroidism. The condition is common among women and old population.

Types:

  • Primary hypothyroidism - caused by disease to thyroid gland itself and is the most common cause of hypothyroidism.
  • Secondary hypothyroidism- dysfunction of pituitary gland or hypothalamus

Drugs:

  • Levothyroxine (synthetic T4) is the most commonly prescribed drug
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Azienda USL Modena
  • Bracco S.p.A.
  • GlaxoSmithKline
  • Ipe, LLC
  • Shri Karthikeya Pharma
  • UNI-PHARMA SA
  • MORE

1 Table of Contents
1.1 List of Figures
1.2 List of Tables

2 Executive Summary
2.1 Report Guide
2.2 Key Findings
2.2.1 Overview of Global Clinical Trials Initiated in 2017
2.2.2 Average Enrolment by Country, 2010 - 2017
2.2.3 Prominent Companies in Global Hypothyroidism Trials, 2010 - 2017

3 Hypothyroidism Drugs in Ongoing and Completed Trials
3.1 Prominent Drugs in Development and Approved Stages for Hypothyroidism
3.2 Hypothyroidism Product Snapshots
3.2.1 Hypothyroidism Drug Profiles

4 Global Hypothyroidism Clinical Trial Research Trends
4.1 Clinical Trials by Top 10 Countries, 2010 - 2017
4.1.1 Clinical Trials by Country
4.1.2 Number of Ongoing/Planned Trial Locations in Each Country
4.2 Subjects Recruited by Top 10 Countries, 2010 - 2017
4.2.1 Total Enrolment by Country
4.3 Clinical Trials by Region, 2010 - 2017
4.4 Subjects Recruited by Region, 2010 - 2017
4.5 Clinical Trials by Year, 2010 - 2017
4.6 Subjects Recruited by Year, 2010 - 2017
4.7 Clinical Trials by Development Phase, 2010 - 2017
4.7.1 Clinical Trials by Phase
4.8 Subjects Recruited by Development Phase, 2010 - 2017
4.9 Clinical Trials by Status, 2010 - 2017
4.10 Subjects Recruited by Trial Status, 2010 - 2017
4.11 Clinical Trials by Sponsor Type, 2010 - 2017
4.12 Subjects Recruited by Sponsor Type, 2010 - 2017
4.13 Clinical Trials by Economy Type, 2010 - 2017
4.14 Clinical Trials and Subjects Recruited by Study Type, 2010 - 2017

5 Europe Hypothyroidism Clinical Trial Research Trends
5.1 Clinical Trials by Top Countries in Europe, 2010 - 2017
5.1.1 Europe, Clinical Trials by Country
5.2 Subjects Recruited by Top Countries in Europe, 2010 - 2017
5.2.1 Europe, Total Enrolment by Country
5.3 Europe, Clinical Trials by Year, 2010 - 2017
5.4 Europe, Clinical Trials by Development Phase, 2010 - 2017
5.5 Europe, Clinical Trials by Trial Status, 2010 - 2017
5.6 Europe, Clinical Trials by Sponsor Type, 2010 - 2017

6 North America Hypothyroidism Clinical Trial Research Trends
6.1 Clinical Trials by Top Countries in North America, 2010 - 2017
6.1.1 North America, Clinical Trials by Country
6.2 Subjects Recruited by Top Countries in North America, 2010 - 2017
6.2.1 North America, Total Enrolment by Country
6.3 North America, Clinical Trials by Year, 2010 - 2017
6.4 North America, Clinical Trials by Development Phase, 2010 - 2017
6.5 North America, Clinical Trials by Trial Status, 2010 - 2017
6.6 North America, Clinical Trials by Sponsor Type, 2010 - 2017

7 Eastern Mediterranean Hypothyroidism Clinical Trial Research Trends
7.1 Clinical Trials by Top Countries in Eastern Mediterranean, 2010 - 2017
7.1.1 Eastern Mediterranean, Clinical Trials by Country
7.2 Subjects Recruited by Top Countries in Eastern Mediterranean, 2010 - 2017
7.2.1 Eastern Mediterranean, Total Enrolment by Country
7.3 Eastern Mediterranean, Clinical Trials by Year, 2010 - 2017
7.4 Eastern Mediterranean, Clinical Trials by Development Phase, 2010 - 2017
7.5 Eastern Mediterranean, Clinical Trials by Trial Status, 2010 - 2017
7.6 Eastern Mediterranean, Clinical Trials by Sponsor Type, 2010 - 2017

8 Western Pacific Hypothyroidism Clinical Trial Research Trends
8.1 Clinical Trials by Top Countries in Western Pacific, 2010 - 2017
8.1.1 Western Pacific, Clinical Trials by Country
8.2 Subjects Recruited by Top Countries in Western Pacific, 2010 - 2017
8.2.1 Western Pacific, Total Enrolment by Country
8.3 Western Pacific, Clinical Trials by Year, 2010 - 2017
8.4 Western Pacific, Clinical Trials by Development Phase, 2010 - 2017
8.5 Western Pacific, Clinical Trials by Trial Status, 2010 - 2017
8.6 Western Pacific, Clinical Trials by Sponsor Type, 2010 - 2017

9 South East Asia Hypothyroidism Clinical Trial Research Trends
9.1 Clinical Trials by Top Countries in South East Asia, 2010 - 2017
9.1.1 South East Asia, Clinical Trials by Country
9.2 Subjects Recruited by Top Countries in South East Asia, 2010 - 2017
9.2.1 South East Asia, Total Enrolment by Country
9.3 South East Asia, Clinical Trials by Year, 2010 - 2017
9.4 South East Asia, Clinical Trials by Development Phase, 2010 - 2017
9.5 South East Asia, Clinical Trials by Trial Status, 2010 - 2017
9.6 South East Asia, Clinical Trials by Sponsor Type, 2010 - 2017

10 South and Central America Hypothyroidism Clinical Trial Research Trends

11 Recent Clinical Trials - Snapshots
11.1 Hypothyroidism Trial Snapshots - 2017
11.2 Hypothyroidism Trial Snapshots - 2016
11.3 Hypothyroidism Trial Snapshots - 2015
11.4 Hypothyroidism Trial Snapshots - 2014
11.5 Hypothyroidism Trial Snapshots - 2013
11.6 Hypothyroidism Trial Snapshots - 2012
11.7 Hypothyroidism Trial Snapshots - 2011
11.8 Hypothyroidism Trial Snapshots - 2010

12 Appendix
12.1 About the Publisher
12.2 Sources and Research Methodology

List of Figures:
Figure 1: Hypothyroidism - Average Enrolment by Country, 2010 - 2017
Figure 2: Hypothyroidism - Country wise Clinical Trials, 2010 - 2017
Figure 3: Hypothyroidism - Country wise Recruiting Sites, 2010 - 2017
Figure 4: Hypothyroidism - Country wise Subjects Recruited, 2010 - 2017
Figure 5: Global Hypothyroidism Clinical Trials Participation Share by Region, 2010 - 2017
Figure 6: Global Hypothyroidism Subjects Recruited by Region, 2010 - 2017
Figure 7: Global Hypothyroidism Clinical Trials by Year, 2010 - 2017
Figure 8: Global Hypothyroidism Subjects Recruited by Year, 2010 - 2017
Figure 9: Global Hypothyroidism Trials by Phase, 2010 - 2017
Figure 10: Global Hypothyroidism - Subjects Recruited by Phase, 2010 - 2017
Figure 11: Global Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 12: Global Hypothyroidism - Subjects Recruited by Trial Status, 2010 - 2017
Figure 13: Global Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017
Figure 14: Global Hypothyroidism - Subjects Recruited by Trial Status, 2010 - 2017
Figure 15: Global Hypothyroidism - Clinical Trials by Type of Economy, 2010 - 2017
Figure 16: Europe Hypothyroidism - Country wise Clinical Trials, 2010 - 2017
Figure 17: Europe Hypothyroidism - Country wise Subjects Recruited, 2010 - 2017
Figure 18: Europe Hypothyroidism - Year wise Clinical Trials, 2010 - 2017
Figure 19: Europe Hypothyroidism Trials by Phase, 2010 - 2017
Figure 20: Europe Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 21: Europe Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017
Figure 22: North America Hypothyroidism - Year wise Clinical Trials, 2010 - 2017
Figure 23: North America Hypothyroidism Trials by Phase, 2010 - 2017
Figure 24: North America Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 25: North America Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017
Figure 26: Eastern Mediterranean Hypothyroidism - Country wise Clinical Trials, 2010 - 2017
Figure 27: Eastern Mediterranean Hypothyroidism - Country wise Subjects Recruited, 2010 - 2017
Figure 28: Eastern Mediterranean Hypothyroidism - Year wise Clinical Trials, 2010 - 2017
Figure 29: Eastern Mediterranean Hypothyroidism Trials by Phase, 2010 - 2017
Figure 30: Eastern Mediterranean Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 31: Eastern Mediterranean Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017
Figure 32: Western Pacific Hypothyroidism - Country wise Clinical Trials, 2010 - 2017
Figure 33: Western Pacific Hypothyroidism - Country wise Subjects Recruited, 2010 - 2017
Figure 34: Western Pacific Hypothyroidism - Year wise Clinical Trials, 2010 - 2017
Figure 35: Western Pacific Hypothyroidism Trials by Phase, 2010 - 2017
Figure 36: Western Pacific Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 37: Western Pacific Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017
Figure 38: South East Asia Hypothyroidism - Year wise Clinical Trials, 2010 - 2017
Figure 39: South East Asia Hypothyroidism Trials by Phase, 2010 - 2017
Figure 40: South East Asia Hypothyroidism - Clinical Trials by Recruitment Status, 2010 - 2017
Figure 41: South East Asia Hypothyroidism - Clinical Trials by Sponsor Type, 2010 - 2017

List of Tables:
Table 1: Hypothyroidism Pipeline Drug Profiles - Type, Class, Route of Administration, Mechanism of Action, Target (1)
Table 2: Hypothyroidism - Region wise Clinical Trials, 2010 - 2017
Table 3: Hypothyroidism - Region wise Subjects Recruited, 2010 - 2017
Table 4: Global Hypothyroidism - Clinical Trials and Subjects by Trial Type, 2010 - 2017
Table 5: Hypothyroidism Trial Snapshots - 2017
Table 6: Hypothyroidism Trial Snapshots - 2017
Table 7: Hypothyroidism Trial Snapshots - 2017
Table 8: Hypothyroidism Trial Snapshots - 2017
Table 9: Hypothyroidism Trial Snapshots - 2017
Table 10: Hypothyroidism Trial Snapshots - 2017
Table 11: Hypothyroidism Trial Snapshots - 2017
Table 12: Hypothyroidism Trial Snapshots - 2017
Table 13: Hypothyroidism Trial Snapshots - 2017
Table 14: Hypothyroidism Trial Snapshots - 2017
Table 15: Hypothyroidism Trial Snapshots - 2017
Table 16: Hypothyroidism Trial Snapshots - 2017
Table 17: Hypothyroidism Trial Snapshots - 2016
Table 18: Hypothyroidism Trial Snapshots - 2016
Table 19: Hypothyroidism Trial Snapshots - 2016
Table 20: Hypothyroidism Trial Snapshots - 2016
Table 21: Hypothyroidism Trial Snapshots - 2016
Table 22: Hypothyroidism Trial Snapshots - 2016
Table 23: Hypothyroidism Trial Snapshots - 2016
Table 24: Hypothyroidism Trial Snapshots - 2016
Table 25: Hypothyroidism Trial Snapshots - 2016
Table 26: Hypothyroidism Trial Snapshots - 2016
Table 27: Hypothyroidism Trial Snapshots - 2016
Table 28: Hypothyroidism Trial Snapshots - 2015
Table 29: Hypothyroidism Trial Snapshots - 2015
Table 30: Hypothyroidism Trial Snapshots - 2015
Table 31: Hypothyroidism Trial Snapshots - 2015
Table 32: Hypothyroidism Trial Snapshots - 2015
Table 33: Hypothyroidism Trial Snapshots - 2015
Table 34: Hypothyroidism Trial Snapshots - 2015
Table 35: Hypothyroidism Trial Snapshots - 2015
Table 36: Hypothyroidism Trial Snapshots - 2015
Table 37: Hypothyroidism Trial Snapshots - 2015
Table 38: Hypothyroidism Trial Snapshots - 2015
Table 39: Hypothyroidism Trial Snapshots - 2014
Table 40: Hypothyroidism Trial Snapshots - 2014
Table 41: Hypothyroidism Trial Snapshots - 2014
Table 42: Hypothyroidism Trial Snapshots - 2014
Table 43: Hypothyroidism Trial Snapshots - 2014
Table 44: Hypothyroidism Trial Snapshots - 2014
Table 45: Hypothyroidism Trial Snapshots - 2014
Table 46: Hypothyroidism Trial Snapshots - 2014
Table 47: Hypothyroidism Trial Snapshots - 2014
Table 48: Hypothyroidism Trial Snapshots - 2014
Table 49: Hypothyroidism Trial Snapshots - 2013
Table 50: Hypothyroidism Trial Snapshots - 2013
Table 51: Hypothyroidism Trial Snapshots - 2013
Table 52: Hypothyroidism Trial Snapshots - 2013
Table 53: Hypothyroidism Trial Snapshots - 2013
Table 54: Hypothyroidism Trial Snapshots - 2013
Table 55: Hypothyroidism Trial Snapshots - 2013
Table 56: Hypothyroidism Trial Snapshots - 2013
Table 57: Hypothyroidism Trial Snapshots - 2013
Table 58: Hypothyroidism Trial Snapshots - 2013
Table 59: Hypothyroidism Trial Snapshots - 2013
Table 60: Hypothyroidism Trial Snapshots - 2013
Table 61: Hypothyroidism Trial Snapshots - 2013
Table 62: Hypothyroidism Trial Snapshots - 2013
Table 63: Hypothyroidism Trial Snapshots - 2013
Table 64: Hypothyroidism Trial Snapshots - 2013
Table 65: Hypothyroidism Trial Snapshots - 2013
Table 66: Hypothyroidism Trial Snapshots - 2013
Table 67: Hypothyroidism Trial Snapshots - 2013
Table 68: Hypothyroidism Trial Snapshots - 2012
Table 69: Hypothyroidism Trial Snapshots - 2012
Table 70: Hypothyroidism Trial Snapshots - 2012
Table 71: Hypothyroidism Trial Snapshots - 2012
Table 72: Hypothyroidism Trial Snapshots - 2012
Table 73: Hypothyroidism Trial Snapshots - 2012
Table 74: Hypothyroidism Trial Snapshots - 2012
Table 75: Hypothyroidism Trial Snapshots - 2012
Table 76: Hypothyroidism Trial Snapshots - 2012
Table 77: Hypothyroidism Trial Snapshots - 2012
Table 78: Hypothyroidism Trial Snapshots - 2012
Table 79: Hypothyroidism Trial Snapshots - 2011
Table 80: Hypothyroidism Trial Snapshots - 2011
Table 81: Hypothyroidism Trial Snapshots - 2011
Table 82: Hypothyroidism Trial Snapshots - 2011
Table 83: Hypothyroidism Trial Snapshots - 2011
Table 84: Hypothyroidism Trial Snapshots - 2011
Table 85: Hypothyroidism Trial Snapshots - 2011
Table 86: Hypothyroidism Trial Snapshots - 2011
Table 87: Hypothyroidism Trial Snapshots - 2011
Table 88: Hypothyroidism Trial Snapshots - 2010
Table 89: Hypothyroidism Trial Snapshots - 2010
Table 90: Hypothyroidism Trial Snapshots - 2010
Table 91: Hypothyroidism Trial Snapshots - 2010
Table 92: Hypothyroidism Trial Snapshots - 2010

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA
  • Azienda USL Modena
  • Bracco S.p.A.
  • GlaxoSmithKline
  • GlaxoSmithKline Pharmaceuticals Ltd
  • IBSA Institut Biochimique SA
  • Ipe, LLC
  • Shri Karthikeya Pharma
  • Takeda Pharmaceutical Company Ltd
  • UNI-PHARMA SA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll